Skip to main content

2024 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Kip Conner, Ph.D.

Scientific Director
Amgen Inc.

Poster(s):

(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities

Monday, October 21, 2024
9:30 AM – 10:30 AM MT